Regulation of CaMKII signaling in cardiovascular disease
Heart failure (HF) is a major cause of death in the developed countries (Murray and Lopez, 1996; Koitabashi and Kass, 2012). Adverse cardiac remodeling that precedes heart muscle dysfunction is characterized by a myriad of molecular changes affecting the cardiomyocyte. Among these, alterations in pr...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
25 August 2015
|
| In: |
Frontiers in pharmacology
Year: 2015, Jahrgang: 6 |
| ISSN: | 1663-9812 |
| DOI: | 10.3389/fphar.2015.00178 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.3389/fphar.2015.00178
|
| Verfasserangaben: | Mariya Y. Mollova, Hugo A. Katus and Johannes Backs |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 157172432X | ||
| 003 | DE-627 | ||
| 005 | 20230426124232.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180405s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fphar.2015.00178 |2 doi | |
| 035 | |a (DE-627)157172432X | ||
| 035 | |a (DE-576)50172432X | ||
| 035 | |a (DE-599)BSZ50172432X | ||
| 035 | |a (OCoLC)1341001680 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Kronlage, Mariya |d 1985- |e VerfasserIn |0 (DE-588)1018185208 |0 (DE-627)680404155 |0 (DE-576)355186217 |4 aut | |
| 245 | 1 | 0 | |a Regulation of CaMKII signaling in cardiovascular disease |c Mariya Y. Mollova, Hugo A. Katus and Johannes Backs |
| 264 | 1 | |c 25 August 2015 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 05.04.2018 | ||
| 520 | |a Heart failure (HF) is a major cause of death in the developed countries (Murray and Lopez, 1996; Koitabashi and Kass, 2012). Adverse cardiac remodeling that precedes heart muscle dysfunction is characterized by a myriad of molecular changes affecting the cardiomyocyte. Among these, alterations in protein kinase pathways play often an important mediator role since they link upstream pathologic stress signaling with downstream regulatory programs and thus affect both the structural and functional integrity of the heart muscle. In the context of cardiac disease, a profound understanding for the overriding mechanisms that regulate protein kinase activity (protein-protein interactions, post-translational modifications, or targeting via anchoring proteins) is crucial for the development of specific and effective pharmacological treatment strategies targeting the failing myocardium. In this review, we focus on several mechanisms of upstream regulation of Ca(2+)-calmodulin-dependent protein kinase II that play a relevant pathophysiological role in the development and progression of cardiovascular disease; precise targeting of these mechanisms might therefore represent novel and promising tools for prevention and treatment of HF. | ||
| 700 | 1 | |a Katus, Hugo |d 1951- |e VerfasserIn |0 (DE-588)108916618 |0 (DE-627)577155040 |0 (DE-576)289625076 |4 aut | |
| 700 | 1 | |a Backs, Johannes |d 1971- |e VerfasserIn |0 (DE-588)123819040 |0 (DE-627)706437462 |0 (DE-576)293892946 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Frontiers in pharmacology |d Lausanne : Frontiers Media, 2010 |g 6(2015) Artikel-Nummer 178, 8 Seiten |h Online-Ressource |w (DE-627)642889392 |w (DE-600)2587355-6 |w (DE-576)335527108 |x 1663-9812 |7 nnas |a Regulation of CaMKII signaling in cardiovascular disease |
| 773 | 1 | 8 | |g volume:6 |g year:2015 |g extent:8 |a Regulation of CaMKII signaling in cardiovascular disease |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3389/fphar.2015.00178 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180405 | ||
| 993 | |a Article | ||
| 994 | |a 2015 | ||
| 998 | |g 123819040 |a Backs, Johannes |m 123819040:Backs, Johannes |d 910000 |d 910100 |e 910000PB123819040 |e 910100PB123819040 |k 0/910000/ |k 1/910000/910100/ |p 3 |y j | ||
| 998 | |g 108916618 |a Katus, Hugo |m 108916618:Katus, Hugo |d 910000 |d 910100 |e 910000PK108916618 |e 910100PK108916618 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 999 | |a KXP-PPN157172432X |e 3004977354 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"name":{"displayForm":["Mariya Y. Mollova, Hugo A. Katus and Johannes Backs"]},"note":["Gesehen am 05.04.2018"],"recId":"157172432X","person":[{"role":"aut","family":"Kronlage","display":"Kronlage, Mariya","given":"Mariya"},{"role":"aut","family":"Katus","given":"Hugo","display":"Katus, Hugo"},{"display":"Backs, Johannes","given":"Johannes","role":"aut","family":"Backs"}],"id":{"doi":["10.3389/fphar.2015.00178"],"eki":["157172432X"]},"physDesc":[{"extent":"8 S."}],"title":[{"title":"Regulation of CaMKII signaling in cardiovascular disease","title_sort":"Regulation of CaMKII signaling in cardiovascular disease"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"25 August 2015"}],"relHost":[{"origin":[{"dateIssuedKey":"2010","publisherPlace":"Lausanne","publisher":"Frontiers Media","dateIssuedDisp":"2010-"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2587355-6"],"issn":["1663-9812"],"eki":["642889392"]},"title":[{"title_sort":"Frontiers in pharmacology","title":"Frontiers in pharmacology"}],"recId":"642889392","disp":"Regulation of CaMKII signaling in cardiovascular diseaseFrontiers in pharmacology","type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["2010 -"],"note":["Gesehen am 08.09.20"],"part":{"year":"2015","volume":"6","text":"6(2015) Artikel-Nummer 178, 8 Seiten","extent":"8"},"language":["eng"]}]} | ||
| SRT | |a KRONLAGEMAREGULATION2520 | ||